See every side of every news story
Published loading...Updated

Carole Imbert appointed as CFO of Vect-Horus - Pharmafile

Summary by pharmafile.com
Vect-Horus has announced it has appointed Carole Imbert as chief financial officer (CFO) and to its executive committee. Vect-Horus is a biotechnology company that designs and develops molecular vectors allowing targeted delivery of therapeutic molecules and imaging agents to organs. Imbert specialises in financial management and structuring. She previously served as head of financial and […] The post Carole Imbert appointed as CFO of Vect-Horus…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

pharmafile.com broke the news in on Friday, March 28, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.